SUBSCRIPTIONS |
|
DTCNews Subscription
|
|
|
|
We accept |
|
|
|
|
|
Vacacionar Travel S.A. use Credit du Nord as a guarantee of absolute security in credit card transactions. |
|
|
|
|
|
|
|
|
|
|
|
:
|
|
|
|
|
|
|
|
|
|
|
|
New Cuban Drug at Primary Healthcare Level |
|
|
Monday, July 8, 2019
Havana.- The healthcare system in the western Cuban province of Pinar del Rio is administering the drug HeberFERON at the primary level.
Created by the Havana-based Genetic Engineering and Biotechnology Center (CIGB), HeberFERON is used with positive results in the treatment of basal cell carcinoma, a type of skin cancer.
So far, some 70 people have benefited from the product, 57 of whom completed their treatment after their injuries disappeared.
Studies reveal the relationship between these tumors and the ultraviolet radiation of the sun, since over the past decade, an increase in its incidence has been reported.
The use of HeberFERON is indicated in the perilesional (intradermal) or intralesional treatment of basal cell carcinoma, previously confirmed by a biopsy.
|
|
|
|
|
|
|
|